Year Wise Statistics
Total Downloads
92,911
Fulltext
79,266
PDF
13,645
92,911
Fulltext
79,266
13,645
| Articles | Fulltext downloads | PDF downloads | Total downloads |
|---|---|---|---|
Case ReportCHEK2 gene in metastatic prostate cancer: A cordial check on DNA damage repair pathwayFull text |  PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_25_2022 |
4,154 | 491 | 4,645 |
EditorialEditorialFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_23_2022 |
4,230 | 102 | 4,332 |
Short CommunicationDriver mutations in oncogenesisFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020 |
4,043 | 166 | 4,209 |
EditorialBench to clinic – Molecular oncology fast tracking curesFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2023 |
3,316 | 665 | 3,981 |
Review ArticleArtificial intelligence in radiation oncology: How far have we reached?Full text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_32_2022 |
2,795 | 778 | 3,573 |
Molecular Insight StorySystemic mastocytosis with an associated hematological neoplasm (acute myeloid leukaemia with RUNX1::RUNX1T1 fusion) – A case studyFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2023 |
2,532 | 627 | 3,159 |
Original ArticleThe effects of expressive writing intervention in cancer patients and survivors: A rapid umbrella reviewFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_24_2022 |
2,538 | 500 | 3,038 |
Review ArticleHER2 ‘neu’ promise for mCRCFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2022 |
2,387 | 645 | 3,032 |
Review ArticleMyeloid neoplasms on poly (ADP-ribose) polymerase inhibitor therapyFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2022 |
2,894 | 97 | 2,991 |
Original ArticleRole of fiberoptic bronchoscopy-guided needle aspiration cytology (EBNA) in diagnosing lung cancer in endobronchial lesions: A single-center experienceFull text | PDF Year: 2023, Volume: 8, Issue: 1, January-April DOI: 10.25259/IJMIO_31_2022 |
2,452 | 453 | 2,905 |
NewsEditorial board tribute to Dr. Amit VermaFull text | PDF Year: 2021, Volume: 6, Issue: 3, September-December |
1,987 | 110 | 2,097 |
Brief CommentaryBreast cancer prognostic tools: A promising Indian optionFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020 |
1,996 | 75 | 2,071 |
Case ReportComplete metabolic response with letrozole and palbociclib in advanced breast cancerFull text | PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019 |
1,742 | 97 | 1,839 |
Short CommunicationOutcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in BangladeshFull text | PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020 |
1,684 | 97 | 1,781 |
Letter to EditorLetter to editorFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022 |
1,582 | 100 | 1,682 |
Review ArticleThe Cancer Genomic Atlas – “TO CONQUER CANCER”Full text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020 |
1,399 | 82 | 1,481 |
Review ArticleAdvances in immunotherapy for metastatic esophageal cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022 |
1,249 | 147 | 1,396 |
Review ArticleIs continuous infusion of high-dose ifosfamide, a safe option? Drug reviewFull text | PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019 |
1,235 | 93 | 1,328 |
Review ArticleClinical application of molecular genetics in acute myeloid leukemiaFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_22_2022 |
1,160 | 150 | 1,310 |
Review ArticleMolecular targets in urinary bladder cancerFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_4_2022 |
1,105 | 107 | 1,212 |
Case ReportA rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lungFull text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2022 |
994 | 119 | 1,113 |
Review ArticleCan CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teachingFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022 |
956 | 135 | 1,091 |
Cardio Oncology with ACOSIbrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survivalFull text | PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022 |
959 | 86 | 1,045 |
Review ArticleSevere acute respiratory syndrome coronavirus 2: Mutations and variants of concern – the Indian scenarioFull text | PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_14_2021 |
942 | 86 | 1,028 |
Review ArticlePARP inhibitors in metastatic prostate cancer: When, who, and how?Full text | PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_19_2022 |
892 | 121 | 1,013 |
